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Abstract
Objective—Commonly, patients undergoing craniotomy are admitted to an intensive care setting
post-operatively to allow for close monitoring. We aim to determine the frequency with which
patients who have undergone elective craniotomies require intensive care unit level interventions
or experience significant complications during the post-operative period to identify a subset of
patients for whom an alternative to ICU level care may be appropriate.
Methods—Following Institutional Review Board approval, a prospective, consecutive cohort of
adult patients undergoing elective craniotomy was established at the Massachusetts General
Hospital between the dates of April 2010 and March 2011. Inclusion criteria were intradural
operations requiring craniotomy performed on adults (18 years of age or greater). Exclusion
criteria were cases of an urgent or emergent nature, patients who remained intubated post-
operatively, and patients who had a ventriculostomy drain in place at the conclusion of the case.
Results—400 patients were analyzed. Univariate analysis revealed that diabetics (p = 0.00047),
patients who required intra-operative blood product administration (p = 0.032), older patients (p <
0.0001), patients with higher intra-operative blood losses (p = 0.041), and patients who underwent
longer surgical procedures (p = 0.021) were more likely to require ICU-level interventions or
experience significant post-operative complications. Multivariate analysis only found diabetes (p =
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0.0005) and age (p = 0.0091) to be predictive of a patient’s need for post-operative intensive care
unit admission.
Conclusions—Diabetes and older age predict the need for ICU-level intervention after elective
craniotomy. Properly selected patients may not require post-craniotomy ICU monitoring. Further
study of resource utilization is necessary to validate these preliminary findings, particularly in
different hospital types.
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Introduction
A 1994 retrospective study of national intensive care unit (ICU) costs in Veterans Affairs’
Hospitals revealed that while ICU beds comprise less than 10% of inpatient hospital beds
nationally, they make up 22% of total hospital costs, equating to roughly 1% of the United
States gross domestic product.(11,12) Recent estimates suggest that ICU costs may approach
1/3 of total inpatient costs at some hospitals, as the cost of a day in the ICU remains roughly
three to five times greater than a day on a general medical/surgical floor.(8,18,19,23) As a
result, considerable efforts have been made to reduce ICU over-utilization.(27) This may be
achieved by minimizing the number of unnecessary ICU admissions by stratifying
postoperative patients by need. Morasch et al. used this approach to ICU utilization
reduction in demonstrating that patients could be safely transferred to a surgical floor
following carotid endarterectomy (CEA) if they remained neurologically and
hemodynamically stable for three hours post-operatively.(20) 79% of the 185 patients who
underwent CEA in this study were successfully transferred to a surgical floor without a
single patient from this group requiring transfer to an ICU or a return to the operating room.
Many neurosurgical patients have been managed successfully postoperatively in a non-ICU
setting, although the analysis of such is limited to retrospective review.(3)
While controversial, it must be noted that a few clinicians in Canada, and more recently in
the United Kingdom (UK), have performed craniotomies for tumor resection in select
patients on a day-surgery basis.(4,5,10) The combined results from an 11-year series from
Toronto Western Hospital (Toronto, Canada) and a 1-year series from Wessex Neurological
Centre (Southampton, UK) showed that of 177 patients scheduled for outpatient craniotomy
for supratentorial tumor resection, only 9 cases required direct post-operative admission and
2 cases required re-admission following discharge.(10) Importantly, none of the patients in
either series suffered an adverse outcome as a result of their planned early discharge. 163 of
the 177 outpatient craniotomy cases were performed as awake procedures and 14 were
performed following the induction of general anesthesia. Both the UK and Canadian groups
only included patients as candidates for outpatient craniotomy if they lived with a
responsible adult, had “no co-morbidity requiring hospitalization,” and had a case
completion time prior to 13:00, allowing for a 6 hour observation period prior to the 19:00
closing time of the surgical units.(10)
Neurosurgeons have generally been reluctant to entertain reductions in post-operative
monitoring following craniotomy, with the fear of not being able to recognize complications
that would require urgent attention. In particular, the development of a post-operative
hematoma is a known complication of any neurosurgical procedure requiring a craniotomy.
Historical literature suggests that roughly 2% of patients undergoing an elective craniotomy
will develop a post-operative hematoma requiring surgical evacuation. However, it is
important to note that the majority of post-operative hematomas will present with clinical
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signs of deterioration within six hours of surgery and are heralded by a clinical
change. (15,24) It is our hope that by further characterizing the patient population undergoing
elective craniotomy, paying special attention to patient co-morbidities and the details of the
neurosurgical procedure performed, we may be able to identify a subset of patients for
whom an alternative to ICU level care in the post-operative period is appropriate.
Methods
Following approval by the Massachusetts General Hospital (MGH) Institutional Review
Board (Protocol #2010P000126) consecutive, adult patients (age > 17 years) undergoing
elective craniotomy by all providers were prospectively collected and observed from April
2010 to March 2011. Consent was not obtained from patients for this observational study
and the MGH Institutional Review Board approved this methodology. Inclusion criteria
included intradural cranial operations, both supratentorial and infratentorial, for indications
including tumor resection, open brain biopsy, vascular malformation obliteration, temporal
lobectomy for epilepsy, microvascular decompression for neurovascular compression
syndromes, and Chiari malformation decompressions. As an institutional practice pattern,
these patients are routinely admitted to the neurological sciences ICU, regardless of
neurological status or clinical complexity at the conclusion of the procedure. In the ICU, the
patient:nursing ratio is either 1:1 or 2:1. Neurological exams are performed by nursing every
1 or 2 hours. Blood pressure is continually monitored with an arterial pressure line for at
least the first 24 hours. Continuous cardiac telemetry and oxygen saturation are monitored.
This differs from the regular neuroscience floor bed, where neurological checks and vital
signs can be obtained every 4 hours. Also, on the floor, the institution of IV drips requires
transfer to the ICU. In rare circumstances because of bed availability, elective craniotomy
patients spent their first post-operative night in the post-operative care unit (PACU) or on
the neurosciences floor and were excluded from the study. Additionally, any craniotomy that
was performed as an urgent or emergent case, defined in the official anesthesia booking
record as requiring a start time in less than four hours or 30 minutes, respectively, was
excluded from this study. Furthermore, patients who remained intubated post-operatively or
had a ventriculostomy drain in place for intracranial pressure monitoring at the conclusion of
the surgery were excluded from the study as these ongoing interventions would always
necessitate an ICU admission.
Details of the operative procedure were recorded from the anesthesia and surgical records
including the type of procedure performed, estimated intra-operative blood loss, use of
blood transfusions, and length of surgery. Tumor volume was calculated with the use of
Vitrea Advanced software (Vital Images, Minnetonka, Minnesota, USA). There was
insufficient power in our pre-study analysis to divide neoplastic lesions into sub-categories
based on pathology. The ICU courses of patients meeting criteria were retrospectively
studied; each patient’s electronic inpatient medical record (including daily progress notes,
event notes, medication records, radiology records, and physician orders) was extracted for
data. Interventions that required an ICU setting, i.e., were not feasible on a general medical/
surgical floor unit, were defined as the use of hemodynamic medications delivered by
intravenous infusion (other than low dose anti-hypertensives: nicardipine at a rate ≤ 5 mg/hr;
cumulative total dose ≤ 20 mg or labetalol at a rate ≤ 10 mg/hr; cumulative total dose ≤ 40
mg), the use of hyperosmolar therapy (defined as the use of 3% NaCl delivered at a rate of
greater than 30 cc/hr or the use of mannitol), the use of an insulin drip, and the use of an ICP
monitor or ventriculostomy drain. Significant adverse events were defined as the
development of a clinically significant post-operative hematoma, ischemic stroke,
myocardial infarction, the need to return to the operating room from the ICU, the need for
re-intubation, goals of patient care being established as comfort measures only (CMO), and
death.
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Statistical analysis was performed using SAS software (version 9.3). Fisher’s Exact test was
used to the determine the association between the need for post-operative intensive care unit
admission and binary risk factors, Chi-Square test was used for categorical risk factors, and
Wilcoxon Rank-Sum tests for continuous factors. A multivariable logistic regression model
was used to test the predictive power of these the significant risk factors on the need for
post-operative intensive care unit admission. Significant variables in the model were
selected according to the stepwise selection process. Significance was defined as p ≤ 0.05.
Results
432 consecutive adult patients underwent elective craniotomy during the study timeframe.
31 cases were excluded as the patients spent the first post-operative nights in the PACU or
on the neurosciences floor, rather than being admitted to the neurological sciences ICU. One
patient died intra-operatively from complications of air emboli during a craniotomy for
tumor and was also excluded from the study. Thereby, 400 elective craniotomy cases were
included in the study population.
There were 166 males and 234 females. The mean age was 53.0, the mean BMI was 28.2,
and the mean American Society of Anesthesiologists (ASA) physical status classification
system score was 2.37. 58 patients were active smokers and 37 had a known pre-operative
diagnosis of diabetes mellitus type II. 123 of the patients studied were admitted to MGH as
inpatients in the immediate pre-operative period, 47 of the patients had been admitted to an
ICU of some kind during the 12-month period prior to their surgery, and 61 of the cases
were repeated craniotomy (“re-do”) cases. The majority (n=298) of patients underwent
supratentorial procedures. Most commonly, general anesthesia was employed (n=386), as
compared to awake craniotomies (n=14). The average surgery length was 263 minutes. The
average intra-operative estimated blood loss (EBL) was 352.5 ml. 46 patients required intra-
operative blood products. (Table 1)
Tumor resection was the most common indication for surgery (n=260), followed by
microsurgical aneurysm obliteration (n=62), microvascular decompression for neurovascular
compression syndrome (n=21), temporal lobectomy for epilepsy (n=19), Chiari
malformation decompression (n=8), cavernous malformation resection (n=5), arteriovenous
malformation resection (n=5), and open tumor biopsy (n=4). Additional categories of
procedures were performed on less than one percent of the study population. (Table 2)
140/400 patients required an ICU level intervention or experienced a significant adverse
event during their post-operative ICU course. The most commonly performed ICU-level
intervention involved continuous intravenous delivery of blood pressure medication. In our
series, 155/400 patients received continuous intravenous blood pressure medications for a
portion of their ICU stay, with the majority of these patients requiring low rate, low
cumulative dose nicardipine, as defined in the methods section. (Figure 1) Assuming that the
short-term use of anti-hypertensive medication by IV drip could be replaced by bolus
antihypertensives administered in the recovery room or on the floor, we performed a subset
analysis by eliminating those patients requiring “minimal” anti-hypertensive therapy.
Removing these cases left 123/400 patients in whom ICU-level intravenous blood pressure
medication drips were used during the post-operative period. Of these 123 patients, 108
required anti-hypertensives (70 nicardipine, 25 labetalol, 13 multiple agents) and 15 required
vasopressors (13 phenylephrine, 1 norephinephrine, 1 multiple agents) to comply with blood
pressure goals.
17 patients required ICU-level hyperosmolar therapy, eight required an insulin drip, three
required intubation (for post-ictal apnea in two cases and significant desaturation thought to
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be related to aspiration in one case), two had to return to the OR from the ICU (for epidural
hematoma in one case and intraparenchymal hematoma in one case), and only one patient
required the placement of an external ventricular drain (for hydrocephalus in the context of
cerebellar edema following acoustic neuroma resection). In addition to ICU-level
interventions, we recorded significant post-operative complications, assuming that these
patients were well-served by the monitoring capacity with which an ICU is equipped. Seven
patients experienced a post-operative ischemic stroke, four patients experienced a clinically
significant hematoma (two of the four resulted in return to the OR), one patient experienced
a myocardial infarction, and there were no patients who died or had therapeutic care
withdrawn (CMO) during their post-operative ICU stay. (Table 3)
Univariate analysis performed on the entire dataset revealed that diabetics (p = 0.00047;
odds ratio [OR] = 3.45, 95% confidence interval [95% CI] = 1.72 – 6.94), patients who
required intra-operative blood product administration (p = 0.032; OR = 2.02, 95% CI = 1.09
– 3.76), older patients (p < 0.0001; OR per year of age = 1.03, 95% CI = 1.015 – 1.045),
patients with higher intra-operative blood losses (p = 0.041; OR per CC of blood loss =
1.001, 95% CI = 1.000 – 1.001), and patients who underwent longer surgical procedures (p
= 0.021; OR per minute of operative time = 1.001, 95% CI = 1.000 – 1.003) were more
likely to require intensive care unit level interventions or experience significant post-
operative complications. (Table 4) Multivariate analysis identified diabetes (p = 0.0005) and
age (p = 0.0091) as predictors of a patient’s need for post-operative intensive care unit
admission.
Of the 140 patients who required ICU-level-of-care interventions or had significant post-
operative complications, 107 (76.4%) of them required an intravenous blood pressure
medication drip as their sole intervention/complication. Therefore, only 33 of the 400
patients in the series (8.25%) required an ICU-level-of-care intervention or had significant
post-operative complication beyond requiring an intravenous blood pressure medication
drip. Additional univariate and multivariate analyses were performed in order to determine if
there were patient or operative variables which were predictive of a patient’s need for an
ICU intervention (or significant post-operative complication) other than administration of
intravenous blood pressure medications. This univariate analysis revealed that diabetics (p =
0.0014; OR = 4.55, 95% CI = 1.93 – 10.75), patients who required intra-operative blood
product administration (p = 0.0019; OR = 4.00, 95% CI = 1.76 – 9.09), patients with higher
ASA status values (p = 0.0008; OR of ASA classes 3 & 4 compared against classes 1 & 2 =
4.636, 95% CI = 2.08 – 10.32), patients with higher intra-operative blood losses (p = 0.015;
OR per CC of blood loss = 1.001, 95% CI = 1.000 – 1.002), and patients who underwent
longer surgical procedures (p = 0.0066; OR per minute of operative time = 1.003, 95% CI =
1.001 – 1.005) were more likely to require intensive care unit level interventions other than
requiring intravenous blood pressure medications. (Table 5) Within this subset of patients,
multivariate analysis identified diabetes (p = 0.0002) the use of intra-operative blood
products (p = 0.0014), and age (p = 0.0215) to be predictive of a patient’s need for post-
operative intensive care unit admission.
In order to better understand the ability of the patient/operative variables identified in our
two univariate analyses to predict a patient’s need for ICU-level care, we tabulated how
many risk-factor free patients ultimately required ICU-level care. In our initial univariate
analysis of the whole patient data set we found that diabetes, intra-operative blood product
administration, greater age, higher intra-operative blood losses, and longer surgical
procedure times were predictive of a patient’s need for the ICU. Selecting for patients who
did not have these risk factors, we identified 239 patients (59.8% of our dataset). Of these
239 patients, 66 patients (or 27.6%) ultimately required ICU-level care.
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Similarly, we analyzed patients who required ICU-level care other than the administration of
hemodynamic intravenous drips. Selecting for patients who were not diabetic, did not
require intra-operative blood products, who were ASA classes 1 or 2, had intra-operative
blood losses less that 1L, and had surgical procedure times of 8 hours or less, we identified
190 patients (47.5% of our dataset). Of these 190 patients, five (2.6%) required ICU-level
care aside from administration of hemodynamic intravenous blood pressure drips. (Table 6)
Discussion
The findings in this study support previous research findings that better risk assessment may
be able to predict the need for ICU-level care following craniotomy. In a retrospective study
of 113 patients undergoing spine surgery or craniotomy for tumor at a single institution,
Nitahara et al. actually found that no patient required active intervention during their ICU
stay.(21) Another study by Ziai et al. attempted to determine variables predictive of the
length of stay and need for ICU intervention in a similar group of 158 patients.(28)
Curiously, they defined IV analgesic use as an ICU level intervention. This accounted for
the majority of their ICU resource utilization. At our institution, IV analgesic use is common
practice on the floor setting and is not an indication for ICU admission. An additional
retrospective study by Bui et al. analyzed 394 patients who underwent elective craniotomy
over a 54-month timeframe (five times the study duration as our study) to assess the need for
ICU admission.(6) The majority of the patients in this study were admitted to the floor
(n=344). Of the 51 patients admitted to the ICU, they found that long operation times,
extensive blood loss, and high anesthesic risks were predictive of ICU admission. Finally,
Rhondali et al. described the occurrence of postoperative complications in 358 patients
admitted to the ICU following elective craniotomy.(22) However, their study design only
defined a postoperative complication as neurological deterioration triggering imaging or
treatment. The results of our study uniquely contribute to a growing body of evidence that
specific risk factors identify the need for ICU-level intervention.
In this study, we have delineated ICU resource utilization by post-operative elective
craniotomy patients in the hope of identifying those for whom ICU-level care may not be
needed. While institutional practice may vary, patterns of care are fairly similar amongst
major medical centers with high-volume neurosurgical practices. Regardless, it should be
emphasized that this is a single institution study and the results may not be generalizable to
other institutions, such as community-based hospitals or other academic institutions. Key
factors, such as hospital size, infrastructure, case volume, proportion of pathological
conditions, local practice standards (including the use of intra-operative and post-operative
imaging), and the level of nursing care available may influence the relative need for post-
operative critical care.
This study is limited by its purely observational nature. Without controlled randomization it
is impossible to assess the true value of post-operative ICU admission for elective
craniotomy patients. There are intangible aspects of ICU care that could not be quantified in
this study, but may impact patient outcomes. For example, the aggressive nursing
monitoring afforded in an ICU setting may have contributed to the low post-operative
complication rates observed in this series. In the ICU, the patient:nurse ratio is either 1:1 or
2:1. Neurological exams are performed by nursing every one or two hours. Our neurological
sciences ICU is equipped with specialized resources: a team of neuro-intensivists that
provides continuous in-unit critical care coverage(25), continuous in-house neurosurgery
coverage, and the resources consistent with status as both an American Heart Association
certified stroke center and an American College of Surgeons level 1 trauma center.(9,16,17)
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The most common ICU-level-of-care intervention observed was the delivery of blood
pressure medication by continuous intravenous infusion. At our institution, all postoperative
craniotomies have arterial line monitoring of continuous blood pressure. A systolic blood
pressure goal of 100-140 mmHg is recorded in the electronic order set for all patients. This
institutional practice pattern is grounded on the understanding that the perioperative course
of patients undergoing intracranial surgery can be complicated by acute hypertensive
episodes, which are associated with intracranial bleeds, resultant morbidity, and prolonged
hospital stays.(11) The high rate of intravenous blood pressure medication drip usage reflects
our institution’s commonly used post-operative systolic blood pressure parameter goal of
100-140 mmHg. Interestingly, the majority of medication usage could be interpreted as low
rate and low cumulative dose, indicative of a relative degree of hemodynamic stability.
There are no randomized controlled trials to support strict adherence to these blood pressure
parameters; however, tight blood pressure control may have contributed to the low rate of
clinically significant post-operative hematomas (1.0%) observed in this study.(1) While it
would be inappropriate to infer the clinical value of maintaining the aforementioned systolic
blood pressure parameters in the post-operative period based on the findings of an
observational study, it is clear that once intravenous blood pressure medication drips are
excluded, relatively few patients in the study population required an ICU-level intervention
or suffered a significant post-operative complication. It is conceivable that patients whose
blood pressure falls slightly outside of these guidelines and are otherwise hemodynamically
stable could be treated in an intermediate care unit.
Close patient monitoring is clearly desirable in the elective craniotomy post-operative
period. However, the low rate of need for ICU interventions other than intravenous blood
pressure medication drips and the even lower rate of significant complications suggest that
these patients rarely utilize the full armamentarium of ICU resources. It may be possible to
compartmentalize post-operative elective craniotomy patients into a lower acuity
neurological ICU or step-down unit where the focus of care can remain on close
neurological monitoring and rapid response rates for patients who experience neurologic or
physiologic deterioration. The benefits of ICU care must be weighed against some of the
disadvantages of being in the ICU postoperatively. For example, physical therapy and
occupational therapy evaluations may be deferred while a patient is in the ICU, sometimes
delaying mobilization. Prompt post-operative mobilization may expedite patient discharge to
home.(26) Additionally, in busy neurosurgical centers with a significant trauma volume,
allocation of ICU beds remains a constant challenge, which could be alleviated by
stratifying post-craniotomy patients into categories of risk and distributing them
postoperatively according to anticipated need.(13,14)
The financial implications of reducing the inappropriate utilization of intensive care are
significant. This holds true even when considering the anticipated “short” intensive care
stays in the immediate post-operative period. For non-ventilated patients, daily costs in the
intensive care unit are highest in the first two days following admission, averaging over
$15,000 total in that period. (7) In another study analyzing a neurosurgery specific
population, immediate transfer to the floor following craniotomy decreased average
hospitalization length by three days and provided an estimated cost savings of $4,026 per
patient.(2) Patients will continue to benefit from further efforts at optimizing resource
utilization both financially and clinically.
Conclusions
Post-operative ICU admission following elective craniotomy is a resource intensive practice.
Diabetes and older age predict the need for ICU-level intervention after elective craniotomy.
It may be reasonable to assign certain post-craniotomy patients to alternative levels of care,
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utilizing hospital resources more efficiently. Further study of resource utilization is
necessary to validate these preliminary findings, particularly in different hospital types.
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Fig. 1.
The majority of the 123 patients treated in the ICU with an intravenous blood pressure
medication received only nicardipine (n= 100). Generally, this medication was delivered at a
low rate (a) and resulted in a small cumulative dose (b) in most patients.
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Table 1
Patient and Operative Characteristics.
Average Age 53.01
Male/Female 166 (41.5%)/234 (58.5%)
Average ASA status 2.37 (n = 395)
Average BMI 28.20 (n = 287)
Diabetes 37 (9.25%)
Active smoker 58 (14.5%)
Pre-operative inpatient admission 123 (30.75%)
ICU admission over prior 12-months 47 (11.75%)
Re-do cases 61 (15.25%)
Supra-/Infratentorial 298 (74.5%)/102 (25.5%)
General anesthesia/Awake 386 (96.5%)/14 (3.5%)
Average surgery length (minutes) 263.36
Average EBL (mLs) 352.50
Received intra-operative blood products 46 (11.5%)
n = 400 unless otherwise noted.
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Table 2
Procedures Performed.
Procedure Performed Number of Cases (%)
Tumor resection 260 (65.0%)
Open aneurysm obliteration 62 (15.5%)
Microvascular decompression 21 (5.25%)
Temporal lobectomy for epilepsy 19 (4.75%)
Chiari malformation decompression 8 (2.0%)
Cavernoma resection 5 (1.25%)
AVM resection 5 (1.25%)
Open biopsy (tumor) 4 (1.0%)
Arachnoid cyst fenestration 3 (0.75%)
EC-IC bypass 3 (0.75%)
Subdural grids and strips 2 (0.5%)
EDAS 1 (0.25%)
Cortical recording 1 (0.25%)
Vestibular nerve sectioning 1 (0.25%)
Corpus callostomy 1 (0.25%)
SCD repair 1 (0.25%)
Encephalocele repair 1 (0.25%)
Open biopsy (autoimmune) 1 (0.25%)
Open biopsy (infectious) 1 (0.25%)
n = 400.
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Table 3
ICU-level Interventions and Post-Operative Complications Necessitating ICU Care.
Measured Outcome Number of Cases (%)
IV blood pressure medication drip 123 (30.75%)
Hyperosmolar therapy 17 (4.25%)
IV insulin drip 8 (2.0%)
Ischemic stroke 7 (1.75%)
Clinically significant hematoma 4 (1.0%)
Intubation 3 (0.75%)
Return to OR 2 (0.5%)
ICP monitor placement 1 (0.25%)
MI 1 (0.25%)
Death/CMO 0 (0.0%)
TOTAL* 140 (35.0%)
n = 400.
*Some patients required more than 1 ICU-level intervention or experienced more than 1 significant complication necessitating ICU care and these
patients were only counted once when calculating the total. Therefore, the sum of all ICU-level interventions and significant complications is more
than the total.
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Table 4
Patient and Operative Variables Predictive of a Need for ICU Care – Univariate Analysis.
Variable Test Performed P Value Odds Ratios (95% Conf. Int.)
Inpatient Status Fisher’s Exact Test 1.00 Inpatient: 0.997 (0.639 – 1.558)
Sex Fisher’s Exact Test 0.17 Male: 1.364 (0.901 – 2.067)
Type (tumor, vascular, functional,
congenital, autoimmune, or
infectious)
Chi-Square 0.12 Tumor (against all others): 0.836 (0.545 – 1.285)
Vascular (against all others): 1.781 (1.072 – 2.958)
Functional (against all others): 0.603 (0.302 – 1.202)
Congenital (against all others): 0.820 (0.248 – 2.713)
Supra- vs. Infra-tentorial Fisher’s Exact Test 0.23 Supratentorial: 0.740 (0.466 – 1.177)
Anesthesia (General vs. Awake) Fisher’s Exact Test 0.40 General: 2.017 (0.553 – 7.355)
Re-do cases Fisher’s Exact Test 0.66 Re-do: 1.148 (0.653 – 2.020)
ASA Status Chi-Square 0.28 Classes 3 & 4 (against 1 & 2): 1.305 (0.854 – 1.994)
Diabetes Fisher’s Exact Test 0.00047 Diabetes: 3.448 (1.715 – 6.944)
Active tobacco smoking Fisher’s Exact Test 0.55 Smoker: 0.812 (0.446 – 1.477)
OR blood products Fisher’s Exact Test 0.032 OR blood product use: 2.024 (1.091 – 3.759)
ICU stay over past 12-months Fisher’s Exact Test 0.33 Prior ICU stay: 0.680 (0.347 – 1.337)
Age Wilcoxon Rank-Sum Test <0.0001 Per year of age: 1.030 (1.015 – 1.045)
EBL Wilcoxon Rank-Sum Test 0.041 Per CC of blood loss: 1.001 (1.000 – 1.001)
BMI Wilcoxon Rank-Sum Test 0.093 Per integer increase in BMI: 1.040 (1.002 – 1.079)
Surgery length Wilcoxon Rank-Sum Test 0.021 Per minute of surgery time: 1.001 (1.000 – 1.003)
Tumor Volume Wilcoxon Rank-Sum Test 0.16 Per CC of tumor volume: 1.007 (0.998 – 1.017)
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Table 5
Patient and Operative Variables Predictive of a Need for ICU Care Other than Intravenous Blood Pressure
Medication Drips – Univariate Analysis.
Variable Test Performed P Value Odds Ratio (95% Conf. Int.)
Inpatient Status Fisher’s Exact Test 0.17 Inpatient: 1.745 (0.844 – 3.610)
Sex Fisher’s Exact Test 0.064 Male: 2.031 (0.987 – 4.178)
Type (tumor, vascular,
functional, congenital,
autoimmune, or infectious)
Chi-Square 0.99 Tumor (against all others): 1.232 (0.569 – 2.668)
Vascular (against all others): 0.943 (0.375 – 2.371)
Functional (against all others): 0.734 (0.215 – 2.506)
Congenital (against all others): 0.925 (0.116 – 7.340)
Supra- vs. Infra-tentorial Fisher’s Exact Test 1.00 Supratentorial: 1.076 (0.469 – 2.467)
Anesthesia (General vs. Awake) Fisher’s Exact Test 1.00 General: 1.175 (0.149 – 9.275)
Re-do cases Fisher’s Exact Test 0.61 Re-do: 1.261 (0.498 – 3.195)
ASA Status Chi-Square 0.0008 Classes 3 & 4 (against 1 & 2): 4.636 (2.083 – 10.318)
Diabetes Fisher’s Exact Test 0.0014 Diabetes: 4.545 (1.927 – 10.753)
Active tobacco smoking Fisher’s Exact Test 1.00 Smoker: 0.800 (0.270 – 2.365)
OR blood products Fisher’s Exact Test 0.0019 OR blood product use: 4.000 (1.764 – 9.091)
ICU stay over past 12-months Fisher’s Exact Test 1.00 Prior ICU stay: 1.040 (0.239 – 3.096)
Age Wilcoxon Rank-Sum Test 0.060 Per year of age: 1.026 (1.002 – 1.051)
EBL Wilcoxon Rank-Sum Test 0.015 Per ml of blood loss: 1.001 (1.000 – 1.002)
BMI Wilcoxon Rank-Sum Test 0.35 Per integer increase in BMI: 1.067 (1.013 – 1.123)
Surgery length Wilcoxon Rank-Sum Test 0.0066 Per minute of surgery time: 1.003 (1.001 – 1.005)
Tumor Volume Wilcoxon Rank-Sum Test 0.44 Per CC of tumor volume: 0.998 (0.981 – 1.016)
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Table 6
Predictive Need for ICU-Level Care Depending on Univariate Analysis Risk Factors.
Risk Factors Overall
Risk Factor Patients with Risk
Factor in the Entire
Series
Patients with Risk
Factor Requiring
ICU-Level Care
Given Risk Factor What
is Likelihood of
Requiring the ICU?
Diabetes 37/400 (9.3%) 20/140 (14.3%) 20/37 (54.1%)
OR blood products 46/400 (11.5%) 22/140 (15.7%) 22/46 (47.8%)
Age > 65 86/400 (21.5%) 43/140 (30.7%) 43/86 (50.0%)
EBL ≥ 1000 20/400 (5.0%) 9/140 (6.4%) 9/20 (45.0%)
Surgery time > 8hrs 37/400 (9.3%) 13/140 (9.3%) 13/37 (35.1%)
NO RISK FACTORS 239/400 (59.8%) 66/140 (47.1%) 66/239 (27.6%)
Risk Factors For Reasons Other than IV BP Medication Infusion
Risk Factor Patients with Risk
Factor in the Entire
Series
Patients with Risk
Factor Requiring
ICU-Level Care
Given Risk Factor
What is Likelihood of
Requiring the ICU?
Diabetes 37/400 (9.3%) 8/33 (24.2%) 8/37 (21.6%)
OR blood products 46/400 (11.5%) 8/33 (24.2%) 8/46 (17.4%)
ASA Classes 3 & 4 151/395 (38.2%) 23/33 (69.7%) 23/151 (15.2%)
EBL ≥ 1000 20/400 (5.0%) 5/33 (15.2%) 5/20 (25.0%)
Surgery time > 8hrs 37/400 (9.3%) 3/33 (9.1%) 3/37 (8.1%)
NO RISK FACTORS 190/400 (47.5%) 5/33 (15.2%) 5/190 (2.6%)
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